Presented by Proffe Invest: Michael Proffe has spent 30+ years spotting powerful market trends, and he turned $30,000 into $3 million with his trend-following strategy. Now he's named 3 stocks he believes could power the next phase of the AI boom. Get the free report revealing all three →

Big checks and big endorsements are doing the lifting this morning. The day's top gainer is a drugmaker that just landed a $2 billion investment from a pharma giant, while a used car retailer blew past estimates and a chipmaker locked in a government development deal.

On the other side, a single post on X was enough to knock 20% off a credit scoring company after a regulator gave a rival a seat at the mortgage pricing table. In some corners of the market, policy can move a stock faster than any earnings report.

He turned $30,000 into 3 million with his trend-following strategy.

Now, he’s zeroed in on 3 stocks he believes could be major beneficiaries of AI’s next phase—and they’re probably not the names you’re expecting.

He reveals all three in this FREE report.

Summit Therapeutics (SMMT): +21%

The drugmaker is surging after AstraZeneca (AZN) agreed to a $2 billion strategic equity investment, alongside a clinical collaboration on two of Summit's cancer drugs, ivonescimab and sonesitatug vedotin. When a pharma giant writes a check that size and signs on to co-develop the pipeline, it reads as outside validation of the science, and investors are pricing it that way.

Navitas Semiconductor (NVTS): +8%

Shares popped after the company secured a government contract to develop next-generation chips, a deal its CTO called a significant milestone for its ultra-high-voltage silicon carbide power devices. A government-backed development program is both a stamp of approval on the technology and a potential source of future business, which is why one contract can move the stock this much.

CarMax (KMX): +6%

The used vehicle retailer blew past Wall Street's second-quarter forecasts, with profit landing far above what analysts expected and revenue topping estimates as well. A beat that wide, rather than a narrow one, is the kind of surprise that forces the street to rethink its numbers going forward.

Bloomin' Brands (BLMN): +5%

The Outback Steakhouse parent is climbing after JPMorgan (JPM) upgraded the stock to Neutral from Underweight. The bank pointed to changes inside the restaurants, including a new steak lineup and cutting each server's peak-hour load from six tables to four. When an analyst drops a bearish call because of operational fixes, it suggests those fixes are starting to register.

Fair Isaac (FICO): -20%

Shares plunged after Federal Housing Finance Agency director Bill Pulte announced on X that the government-backed mortgage giants are moving to a single pricing grid, with VantageScore joining the existing FICO Classic grid. Putting a rival score on equal footing in mortgage pricing raises the risk that Fair Isaac's grip on one of lending's biggest markets starts to loosen, and investors are repricing that risk fast.

He turned $30,000 into 3 million with his trend-following strategy.

Now, he’s zeroed in on 3 stocks he believes could be major beneficiaries of AI’s next phase—and they’re probably not the names you’re expecting.

He reveals all three in this FREE report.

BlackBerry (BB)

BlackBerry is back on the r/wallstreetbets radar, with ApeWisdom showing mentions up 2,000% in the past day and about three-quarters of that chatter reading positive. On StockTwits, sentiment hit "extremely bullish" after last week's earnings, with traders fixated on QNX, the car software unit that retail increasingly treats as a physical AI play rather than a leftover from the phone era.

The company beat estimates and raised its full-year outlook on Thursday as QNX posted record revenue and landed the largest design win in its history, and the stock is up roughly 130% this year. Whether the renewed buzz marks the start of another leg higher or a crowd arriving late to a big run is still an open question.

✌️That’s it for today.